Prostate Cancer Research
Young Investigator Awards
The Prostate Cancer Foundation Human Capital Initiative
Young Investigator Awards
“Supporting a focus on prostate cancer by talented, young investigators is critical to realizing PCF’s goal of accelerating breakthrough discoveries that can potentially end death and suffering from prostate cancer.”
Dr. Howard Soule, PCF Executive Vice President and Chief Science Officer
PCF created the Young Investigator Awards program with one goal: to identify a cohort of future research leaders who will keep the field of prostate cancer research vibrant with new ideas.
The Young Investigator Awards offer career and project support for young (generally 35 and younger) proven investigators who have achieved junior faculty positions and are committing their lives to the field of prostate cancer.
The awards were inspired by Donald S. Coffey, PhD, the Prostate Cancer Research Director at Johns Hopkins University for four decades. He has mentored more than 50 scientists and physician-scientists and trained more than 30 of today’s leading prostate cancer researchers.
The Prostate Cancer Foundation announced the funding of 28 new Young Investigator Awards, which are given to the most innovative minds in the field of prostate cancer research. The total number of PCF Young Investigators funded since 2007 now stands at 118.
The Prostate Cancer Foundation announced the funding of 23 new Young Investigator Awards, a nearly $5 million investment in transformational research focused on prostate cancer treatments to improve patient outcomes. With a total of 97 Investigators, PCF’s YI program spans across six countries and 42 research institutes.
The Prostate Cancer Foundation announced the funding of 24 new Young Investigators Awards, a $5.2 million investment in the global cancer research community. Since 2007, PCF has supported a total of 74 Young Investigators, representing an investment of more than $16 million.
PCF announced the funding of 27 new Young Investigator Awards at 18 leading cancer centers in the U.S. and Canada. Designed to encourage the most innovative minds in cancer research to focus their careers on prostate cancer, the awards provide recipients with three years of funding to test transformational research questions for prostate cancer patients. The 2010 Young Investigator Awards represent a new $5.9 million investment in the global cancer research community by PCF.
With the announcement of the 2010 Young Investigators, PCF is now funding 50 research projects led by young investigators around the world. These Young Investigator projects are three years in duration.
PCF announced its first Young Investigators Awards for 2008. In the end, 23 recipients were chosen by an expert committee comprised of 25 leading scientists and clinicians. True to PCF’s mission of accelerating research, the entire application and selection process was completed within seven weeks of receipt of proposals through electronic submission and review of applications.
Among the highlights:
- PCF received 76 applications from eight countries.
- Proposals focused on 16 different prostate cancer research areas.
- Applicants represented seven medical and scientific disciplines, including medical oncology, radiation oncology, urology, pathology, imaging science and many areas of molecular science.